Influence of antileukemic (L1210) treatment schedule on disposition of (minus)-emetine hydrochloride (NSC 33669) in normal and leukemic mice

Saved in:
Bibliographic Details
Published inCancer research (Chicago, Ill.) Vol. 34; no. 7; pp. 1581 - 1585
Main Authors Auletta, A E, Gery, A M, Mead, J A
Format Journal Article
LanguageEnglish
Published United States 01.07.1974
Subjects
Administration, Oral
Animals
Antineoplastic Agents - administration & dosage
Antineoplastic Agents - metabolism
Antineoplastic Agents - therapeutic use
Emetine - administration & dosage
Emetine - metabolism
Emetine - therapeutic use
Emetine - urine
Feces - analysis
Injections, Intraperitoneal
Intestine, Small - metabolism
Kidney - metabolism
Leukemia L1210 - drug therapy
Leukemia L1210 - metabolism
Liver - metabolism
Male
Mice
Mice, Inbred C57BL
Mice, Inbred DBA
Spectrometry, Fluorescence
Spleen - metabolism
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0008-5472